Integer Holdings Co. (NYSE:ITGR) Receives Consensus Rating of “Moderate Buy” from Analysts

Integer Holdings Co. (NYSE:ITGRGet Free Report) has earned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $133.86.

A number of research analysts recently weighed in on the company. Truist Financial started coverage on Integer in a report on Wednesday, May 15th. They issued a “buy” rating and a $137.00 target price on the stock. Benchmark reiterated a “buy” rating and set a $130.00 target price on shares of Integer in a report on Friday, August 2nd. Oppenheimer initiated coverage on shares of Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target on the stock. Finally, Citigroup boosted their price objective on shares of Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 22nd.

Get Our Latest Stock Report on ITGR

Insider Activity at Integer

In other Integer news, EVP John A. Harris sold 1,521 shares of the company’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $120.44, for a total value of $183,189.24. Following the completion of the transaction, the executive vice president now directly owns 4,922 shares of the company’s stock, valued at approximately $592,805.68. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Integer news, EVP John A. Harris sold 1,521 shares of Integer stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $120.44, for a total transaction of $183,189.24. Following the sale, the executive vice president now directly owns 4,922 shares in the company, valued at approximately $592,805.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. The disclosure for this sale can be found here. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

A number of institutional investors have recently modified their holdings of the stock. Quest Partners LLC increased its holdings in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after buying an additional 142 shares during the last quarter. Principal Securities Inc. acquired a new position in shares of Integer in the 4th quarter valued at about $67,000. Headlands Technologies LLC acquired a new stake in Integer during the first quarter worth about $106,000. Finally, Innealta Capital LLC bought a new position in Integer in the second quarter worth about $110,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

NYSE ITGR opened at $127.55 on Friday. The business’s 50-day moving average price is $118.90 and its 200 day moving average price is $115.90. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. Integer has a twelve month low of $69.40 and a twelve month high of $130.15. The company has a market capitalization of $4.27 billion, a PE ratio of 44.13, a price-to-earnings-growth ratio of 1.70 and a beta of 1.11.

Integer (NYSE:ITGRGet Free Report) last announced its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same period in the prior year, the firm posted $1.14 EPS. The company’s revenue was up 9.0% on a year-over-year basis. On average, research analysts predict that Integer will post 5.31 earnings per share for the current year.

About Integer

(Get Free Report

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Further Reading

Analyst Recommendations for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.